Stay updated with breaking news from Sciences Co. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The wide range of variants of the malaria parasite and the continuous emergence of new ones could affect the efficacy of the world’s first ever malaria vaccine in the country. Research conducted by the Noguchi Memorial Institute for Medical Research (NMIMR) shows varied malaria parasite strains across Ghana. Dr Anita…
Mirae Asset Global Investments Co. Ltd. raised its position in Exact Sciences Co. (NASDAQ:EXAS – Get Rating) by 19.4% during the 1st quarter, according to its most recent filing with the SEC. The firm owned 112,740 shares of the medical research company’s stock after buying an additional 18,357 shares during the quarter. Mirae Asset Global […]
Professor Harold Amonoo-Kuofi, former Provost of the College of Health and Allied Sciences (CoHAS) of the University of Cape Coast (UCC), has underscored the need for health training institutions to integrate effective health related technological innovations into teaching and learning. He said the global revolution in Information and Communication Technology…
Equities analysts forecast that Exact Sciences Co. (NASDAQ:EXAS – Get Rating) will report sales of $498.48 million for the current fiscal quarter, Zacks Investment Research reports. Seven analysts have issued estimates for Exact Sciences’ earnings, with the lowest sales estimate coming in at $492.40 million and the highest estimate coming in at $505.50 million. Exact […]
Analysts expect that Exact Sciences Co. (NASDAQ:EXAS – Get Rating) will post sales of $461.86 million for the current quarter, Zacks Investment Research reports. Seven analysts have made estimates for Exact Sciences’ earnings, with estimates ranging from $458.10 million to $466.90 million. Exact Sciences reported sales of $402.08 million during the same quarter last year, […]